Načítá se...
Can Effluent Matrix Metalloproteinase 2 and Plasminogen Activator Inhibitor 1 Be Used As Biomarkers of Peritoneal Membrane Alterations in Peritoneal Dialysis Patients?
♦ Background: Peritoneal effluent contains clinically relevant substances derived from intraperitoneal production or transperitoneal transport, or both. The glycoproteinase matrix metalloproteinase 2 (MMP-2) cleaves denatured collagen and complements other collagenases in the degradation of fibrilla...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Multimed Inc
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3797671/ https://ncbi.nlm.nih.gov/pubmed/23994841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/pdi.2012.01063 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|